Nutex Health Chairman and CEO Tom Vo to Speak on Panel at Upcoming Danaher Summit on Diagnostics
- None.
- None.
Nutex Health Speaker Details:
Date: Tuesday, November 7, 2023
Time: 1:30 PM ET
Venue: The Ritz Carlton
Address: 1150 22nd Street Northwest,
Dr. Vo will be speaking on Panel 4, "Diagnostic Insights to Impact: The Hospital Director/Healthcare Systems." He will be accompanied by Dr. Michael Zinner, CEO and Executive Medical Director at Miami Cancer Institute, and Dr. T. Clifford Deveny, President and CEO of Summa Health.
About Nutex Health Inc.
Headquartered in
The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 22 facilities in 8 states.
The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups. Our cloud-based proprietary technology platform aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers, allowing us to deliver greater quality care more efficiently.
Forward-Looking Statements
Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act , economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Current Report on Form 10-Q for the period ended March 31, 2023 under the heading "Risk Factors" in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.
View original content:https://www.prnewswire.com/news-releases/nutex-health-chairman-and-ceo-tom-vo-to-speak-on-panel-at-upcoming-danaher-summit-on-diagnostics-301973574.html
SOURCE Nutex Health, Inc.
FAQ
Who will be speaking at the Danaher Summit on Diagnostics?
What is the focus of the summit?
When and where will the summit take place?
Who will Dr. Vo be speaking alongside?
